Literatur
Olié V, Canonico M, Scarabin PY (2010) Risk of venous thrombosis with oral versus trans-dermal estrogen therapy among postmenopausal women. Curr Opin Hematol 17(5):457–463
Løkkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard Ø (2008) Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J 29(21):2660–2668
Manson JE, Chlebowski RT, Stefanick ML et al (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 310(13):1353–1368
Renoux C, Dell’aniello S, Garbe E, Suissa S (2010) Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 340:c2519
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Stute gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
Deutsche Menopause Gesellschaft e. V.
P. Stute, Bern
A.O. Mueck, Tübingen
Rights and permissions
About this article
Cite this article
Stute, P. Risiko von Herz-Kreislauf-Erkrankungen. Gynäkologische Endokrinologie 15, 80–81 (2017). https://doi.org/10.1007/s10304-016-0105-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10304-016-0105-z